KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 56 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,595,295 | +16.6% | 206,983 | -5.5% | 0.00% | 0.0% |
Q2 2023 | $3,084,745 | +31.6% | 219,087 | +0.6% | 0.00% | 0.0% |
Q1 2023 | $2,344,464 | -23.9% | 217,887 | +6.0% | 0.00% | 0.0% |
Q4 2022 | $3,079,244 | +17.3% | 205,557 | +0.5% | 0.00% | 0.0% |
Q3 2022 | $2,626,000 | +224.2% | 204,500 | +144.9% | 0.00% | – |
Q2 2022 | $810,000 | +5.6% | 83,503 | +8.3% | 0.00% | – |
Q1 2022 | $767,000 | -14.8% | 77,082 | +0.8% | 0.00% | – |
Q4 2021 | $900,000 | +6.5% | 76,456 | +3.1% | 0.00% | – |
Q3 2021 | $845,000 | -13.8% | 74,170 | +5.5% | 0.00% | – |
Q2 2021 | $980,000 | -19.1% | 70,296 | +7.4% | 0.00% | – |
Q1 2021 | $1,212,000 | +4.2% | 65,446 | -0.6% | 0.00% | – |
Q4 2020 | $1,163,000 | +15.1% | 65,815 | -0.2% | 0.00% | – |
Q3 2020 | $1,010,000 | -15.8% | 65,921 | +40.1% | 0.00% | -100.0% |
Q2 2020 | $1,199,000 | +118.0% | 47,047 | +32.5% | 0.00% | – |
Q1 2020 | $550,000 | +63.2% | 35,496 | +16.6% | 0.00% | – |
Q4 2019 | $337,000 | +8.7% | 30,440 | -16.4% | 0.00% | – |
Q3 2019 | $310,000 | -36.5% | 36,404 | +1.1% | 0.00% | – |
Q2 2019 | $488,000 | +12.4% | 36,013 | +50.1% | 0.00% | – |
Q1 2019 | $434,000 | +3.6% | 23,992 | +61.0% | 0.00% | – |
Q4 2018 | $419,000 | +10.3% | 14,900 | 0.0% | 0.00% | – |
Q3 2018 | $380,000 | – | 14,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |